You are here:Home-Chemical Inhibitors & Agonists-Ras-Raf-MAPK-ERK Pathway-JNK-AM-111
AM-111

Chemical Structure : AM-111

CAS No.: 1445179-97-4

AM-111 (Brimapitide, KU002, D-JNKI-1, XG-102)

Catalog No.: PC-47480Not For Human Use, Lab Use Only.

Brimapitide (KU002, D-JNKI-1, XG-102, AM-111) is a cell-permeable peptide inhibitor of JNK kinases.

Packing Price Stock Quantity
5 mg $228 In stock
10 mg $368 In stock
25 mg $588 In stock
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Brimapitide (KU002, D-JNKI-1, XG-102, AM-111) is a cell-permeable peptide inhibitor of JNK kinases.
Brimapitide blocks apoptotic JNK signaling in brain mitochondria.
Brimapitide decreases the expression of CD4(+) and CD8(+) cells, effects T-cell activation, differentiation, and migration in a murine model of chronic colitis.
Brimapitide prevents hearing loss from SC transection in the guinea pig model of PA-OM.

Physicochemical Properties

M.Wt 3822.44
Formula C164H286N66O40
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

H2O: >50 mg/mL

Chemical Name/SMILES

NH2-DQSRPVQPFLNLTTPRKPRPPRRRQRRKKRG-COOH

References

1. Eshraghi AA, et al. Otol Neurotol. 2006 Jun;27(4):504-11.

2. Zhao Y, et al. Mol Cell Neurosci. 2012 Mar;49(3):300-10.

3. Kersting S, et al. J Inflamm Res. 2013 May 3;6:71-81.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: